NCT07657286 Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients
| NCT ID | NCT07657286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Badr University |
| Condition | Chronic Kidney Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-06-07 |
| Primary Completion | 2026-09-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-06-07 with a primary completion date of 2026-09-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research intends to analyze how a 12-week adjustment in lifestyle influences inflammatory cytokines and oxidative stress indicators in overweight individuals diagnosed with type 2 diabetes and moderate CKD
Eligibility Criteria
Inclusion Criteria: * sedentary lifestyle for at least three months prior to enrollment * body mass index (BMI) of 30-35 kg/m². Exclusion Criteria: * using tobacco * heart failure * coronary arteries * severe heart valve problems * pregnant * liver inflammation * kidney transplant * physical injuries restricting them from exercising * utilization of anti-inflammatory medications
Contact & Investigator
Mona Mohamed Abdelkhalek
PRINCIPAL INVESTIGATOR
Badr University
Frequently Asked Questions
Who can join the NCT07657286 clinical trial?
This trial is open to participants of all sexes, aged 36 Years or older, up to 58 Years, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07657286 currently recruiting?
Yes, NCT07657286 is actively recruiting participants. Contact the research team at 3m.sons@gmail.com for enrollment information.
Where is the NCT07657286 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07657286 clinical trial?
NCT07657286 is sponsored by Badr University. The principal investigator is Mona Mohamed Abdelkhalek at Badr University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.